A. Menarini GmbH
- C01 - Terapia cardíaca
- RANEXA prolonged-release tablet 375 mg
- RANEXA prolonged-release tablet 500 mg
- RANEXA prolonged-release tablet 750 mg
- C07 - Betabloqueantes
- NEBILET PLUS film-coated tablet 5 mg+12.5 mg
- NEBILET PLUS film-coated tablet 5 mg+25 mg
- NEBILET tablet 5 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- VASCORD film-coated tablet 20 mg+5 mg
- VASCORD film-coated tablet 40 mg+10 mg
- VASCORD film-coated tablet 40 mg+5 mg
- VASCORD HCT film-coated tablet 20 mg+5 mg+12.5 mg
- VASCORD HCT film-coated tablet 40 mg+10 mg+12.5 mg
- VASCORD HCT film-coated tablet 40 mg+10 mg+25 mg
- VASCORD HCT film-coated tablet 40 mg+5 mg+12.5 mg
- VASCORD HCT film-coated tablet 40 mg+5 mg+25 mg
- VOTUM film-coated tablet 10 mg
- VOTUM film-coated tablet 20 mg
- VOTUM film-coated tablet 40 mg
- VOTUM PLUS film-coated tablet 20 mg+12.5 mg
- VOTUM PLUS film-coated tablet 20 mg+25 mg
- VOTUM PLUS film-coated tablet 40 mg+12.5 mg
- VOTUM PLUS film-coated tablet 40 mg+25 mg
- G04 - Urológicos
- PRILIGY film-coated tablet 30 mg
- SPEDRA tablet 100 mg
- SPEDRA tablet 200 mg
- SPEDRA tablet 50 mg
- J01 - Antibacterianos para uso sistémico
- QUOFENIX powder for solution for infusion 300 mg
- QUOFENIX tablet 450 mg
- TENKASI powder for solution for infusion 400 mg
- VABOREM powder and solvent for solution for infusion 1 g+1 g
- J05 - Antivirales de uso sistémico
- BRIVEX tablet 125 mg
- M02 - Productos tópicos para dolor articular y muscular
- FASTUM gel 2.5%
- M04 - Antigotosos
- ADENURIC film-coated tablet 80 mg
- R06 - Antihistamínicos para uso sistémico
- BILAXIN LINGUAL orodispersible tablet 20 mg
- BILAXTEN KIDS oral solution 2.5 mg/ml
- BILAXTEN KIDS orodispersible tablet 10 mg
- BILAXTEN orodispersible tablet 20 mg
- BILAXTEN tablet 20 mg
- S01 - Oftalmológicos
- BILAXTEN eye drops, solution 6 mg/ml